[
  {
    "ts": null,
    "headline": "CorMedix Spikes To Four-Year High On A Surprise Deal For Its Leading Drug",
    "summary": "CorMedix shares bounded to a four-year high Monday after the biotech company inked an expanded deal for its leading drug, DefenCath.",
    "url": "https://finnhub.io/api/news?id=9a48e4dd81f2c5d378a9de15a89d6694de17b488101e6cd30ab3c030bb26d90f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750710391,
      "headline": "CorMedix Spikes To Four-Year High On A Surprise Deal For Its Leading Drug",
      "id": 135485936,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DVA",
      "source": "Yahoo",
      "summary": "CorMedix shares bounded to a four-year high Monday after the biotech company inked an expanded deal for its leading drug, DefenCath.",
      "url": "https://finnhub.io/api/news?id=9a48e4dd81f2c5d378a9de15a89d6694de17b488101e6cd30ab3c030bb26d90f"
    }
  }
]